Alexia Y. Zhang
Oregon Health Authority(US)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Antibiotic Use and Resistance, Antifungal resistance and susceptibility, Urinary Tract Infections Management, Pneumocystis jirovecii pneumonia detection and treatment
Most-Cited Works
- → Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016(2019)188 cited
- → Burden of Candidemia in the United States, 2017(2020)157 cited
- → Assessment of the Appropriateness of Antimicrobial Use in US Hospitals(2021)120 cited
- → Antimicrobial Use in US Hospitals: Comparison of Results From Emerging Infections Program Prevalence Surveys, 2015 and 2011(2020)114 cited
- → RETRACTED: Combining PARP-1 Inhibition and Radiation in Ewing Sarcoma Results in Lethal DNA Damage(2013)86 cited
- → Neonatal and Pediatric Candidemia: Results From Population-Based Active Laboratory Surveillance in Four US Locations, 2009–2015(2018)78 cited
- → The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor—Active Surveillance in Selected Sites, United States, 2014–2017(2019)52 cited
- → Notes from the Field: Late-Onset Infant Group B Streptococcus Infection Associated with Maternal Consumption of Capsules Containing Dehydrated Placenta — Oregon, 2016(2017)49 cited
- → Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia‐inducible factor 1α(2012)41 cited
- → Antimicrobial Use in a Cohort of US Nursing Homes, 2017(2021)39 cited